Refine by
Intravitreal Suppliers & Manufacturers
14 companies found
based inPARIS, FRANCE
FCI is a world leader in the development of a wide range of ophthalmic devices and is dedicated to providing physicians with innovative, high-performance and mostly exclusive products covering the fields of expertise of Oculoplasty, Dry Eye, Retina ...
Precivia is a disposable device that simplifies* intravitreal injections. Its special design ensures a fast, accurate & predictable ...
based inBubendorf, SWITZERLAND
CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technologyœ, says Christoph Schäfer, CEO ...
The Cefuroxime Application System is CIS Pharma’s patented drug/device combination for preparation and injection of cefuroxime intracameral antibiotic to prevent Endophthalmitis. It meets the cataract surgeon’s need to dilute and inject ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
based inWaltham, MASSACHUSETTS (USA)
Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases. Existing therapies for retinal neovascular / exudative diseases have made great ...
Kalaris Therapeutics is focused on developing innovative treatments for retinal diseases, aiming to reduce the burden of frequent clinical visits for patients with retinal neovascular and exudative conditions. Their lead product, TH103, is a fully ...
based inMalvern, PENNSYLVANIA (USA)
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. Our breakthrough modifier gene therapy platform ...
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular Degeneration (Wet-AMD). Patients affected by ...
based inBellshill, UNITED KINGDOM
Since Andersen Caledonia’s origin in 1997 we have continuously advanced the methods used for infection prevention and contamination control to combat the ever-evolving microbiological and environmental challenges faced by our customers. Our ...
SP.eye™ is a single device integrating a delivery guide, 30 gauge needle and sharps safe system to assist in the delivery of intravitreal injections. Developed by Ophthalmologists with extensive experience in ...
based inIrving, TEXAS (USA)
Celanese (NYSE: CE) is a global chemical and specialty materials company that engineers and manufactures a wide variety of products essential to everyday living. Celanese is built on the tradition of using our expertise – chemical intermediates, ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceutical Solutions specializes in comprehensive drug development services, providing tailored formulation and manufacturing solutions from pre-formulation stages to commercialization. With a focus on overcoming pharmaceutical ...
Ascendia offers a range of final dosage form options for our client’s development projects. Our proprietary nanotechnologies allow us to develop enabling formulations for a variety of dosage forms for small molecules and biologics, including ...
based inÇatalca, TURKEY
Meran Medical is a manufacturing company specializing in medical products with a focus on ophthalmic solutions. The company offers a range of products including cannulas for oculoplastic and vitreoretinal surgeries, ophthalmic surgical liquids, ...
This product is part of a broader range of ophthalmic surgical supplies, including cannulas, ophthalmic surgical liquids, and intravitreal injection kits, all designed to support successful surgical outcomes in oculoplastic and ...
based inWoodside, CALIFORNIA (USA)
The Manzanita tree is part of the California chaparral, a genre of native plants that survives brushfires and can thrive even in difficult environments. Manzanita Pharmaceuticals, Inc. was founded in May 2007 with data supported by DARPA in a prior ...
Nervelight™, a topical, intraoperative nerve imaging agent that is selective for at-risk nerve tissue in cancer ...
based inOakville, ONTARIO (CANADA)
We bring innovation and vision to practice globally through principled people. For over 60 years we’ve been world-wide leaders providing advanced eye care products, solutions, and resources for eye care professionals and their patients. Labtician ...
based inMilan, ITALY
MgShell is developing an innovative game changer in the treatment space, an intraocular device able to replicate the current clinical strategy reducing drastically the number of intravitreal injections and all the therapeutical burdens. Our device ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
β-N-methylamino-L-alanine hydrochloride (BMAA hydrochloride) is a neurotoxin produced by cyanobacteria. β-N-methylamino-L-alanine hydrochloride activates mGluR3 and inhibits PKC. β-N-methylamino-L-alanine hydrochloride can be used in the research of ...
based inPlanegg, GERMANY
ViGeneron is based on our passion to deliver gene therapy innovations and advances to people in need. Our proprietary science solves major limitations in current gene therapy approaches. At ViGeneron we are dedicated to developing innovative gene ...
The vgAAV vector platform enables a superior transduction of target cells and is designed to efficiently cross biological barriers. These attributes allow vgAAV vectors to target a broad spectrum of cell types in the retina, thus enabling ...